Treatment and prognostic factors in lymphoma in cats: 103 cases (1977-1981)

J Am Vet Med Assoc. 1989 Mar 1;194(5):696-702.

Abstract

The records of 103 cats with lymphoma that underwent chemotherapy were reviewed. Diagnosis was confirmed by cytologic or histopathologic examination of appropriate tissue specimens. Sixty-four cats (62%) had a complete response to chemotherapy (median survival time, 7 months); 21 cats (20%) had a partial response (median survival time, 2.5 months); and 18 cats had a minimal response (median survival time, 1.5 months). Seventy-seven cats (75%) died of recurrent or progressive lymphoma, 9 cats died of feline leukemia-related anemia, 13 cats died of unrelated causes, and 4 cats were alive. Stage of disease was significantly (P = 0.009) related to response to treatment, and stage of disease and FeLV status were both significantly (P = 0.002 and P less than 0.001, respectively) related to survival.

MeSH terms

  • Animals
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Asparaginase / administration & dosage
  • Cat Diseases / drug therapy*
  • Cats
  • Cyclophosphamide / administration & dosage
  • Female
  • Lymphoma / drug therapy
  • Lymphoma / veterinary*
  • Male
  • Methotrexate / administration & dosage
  • Prednisone / administration & dosage
  • Prognosis
  • Retrospective Studies
  • Vincristine / administration & dosage

Substances

  • Vincristine
  • Cyclophosphamide
  • Asparaginase
  • Prednisone
  • Methotrexate